Ann Donohue
Nessuna posizione attualmente
Profilo
Ann K.
Donohue served as the VP, Chief Financial & Accounting Officer at Selecta Biosciences, Inc. in 2021.
She received her undergraduate and graduate degrees from the Wallace E Carroll School of Management.
Precedenti posizioni note di Ann Donohue
| Società | Posizione | Fine |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Direttore Finanziario/CFO | 20/09/2021 |
Formazione di Ann Donohue
| Wallace E Carroll School of Management | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Borsa valori
- Insiders
- Ann Donohue
